Psychedelics as Therapeutics-Potential and Challenges

Nora D Volkow; Joshua A Gordon; Eric M Wargo

doi:10.1001/jamapsychiatry.2023.1968

Psychedelics as Therapeutics-Potential and Challenges

JAMA Psychiatry. 2023 Oct 1;80(10):979-980. doi: 10.1001/jamapsychiatry.2023.1968.

Authors

Nora D Volkow¹, Joshua A Gordon², Eric M Wargo¹

Affiliations

¹ National Institute on Drug Abuse, Gaithersburg, Maryland.
² National Institute of Mental Health, Bethesda, Maryland.

PMID: 37494019
DOI: 10.1001/jamapsychiatry.2023.1968

No abstract available

Plain language summary

This Viewpoint discusses the potential promise of the therapeutic use of psychedelics for mental illness and substance use disorders, acknowledging many open research questions and unique challenges with these substances.

Publication types

Editorial

MeSH terms

Hallucinogens* / therapeutic use
Humans
Mental Disorders* / drug therapy

Substances

Hallucinogens